Search
long-acting reversible contraception (LARC)
Includes:
- progestin-releasing intrauterine device
- copper-containing intrauterine device
- progestin-only implant
Indications:
- prevention of pregnancy in sexually-active women*
* most effective methods of contraception
* highly effective 2 years beyond FDA-approved time frames [3]
Management:
- prenatal counseling about LARC after childbirth recommended [2]
- women should be offered immediate postpartum LARC [2]
General
contraception
References
- Kavanaugh ML et al.
Changes in use of long-acting reversible contraceptive methods
among U.S. women, 2009-2012.
Obstet Gynecol 2015 Oct 5
PMID: 26444110
- American College of Obsetricians & Gynecologists
Committee Opinion. Number 670, August 2016
http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Immediate-Postpartum-Long-Acting-Reversible-Contraception
- McNicholas C, Swor E, Wan L, Peipert JF.
Prolonged use of the etonogestrel implant and levonorgestrel
intrauterine device - two years beyond FDA-approved duration.
Am J Obstet Gynecol 2017 Jan 29;
PMID: 28147241
http://www.ajog.org/article/S0002-9378(17)30171-0/abstract
- American College of Obstetricians and Gynecologists
Long-Acting Reversible Contraception: Implants and Intrauterine
Devices.
Practice Bulletin. Number 186, November 2017
https://www.acog.org/Resources-And-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Long-Acting-Reversible-Contraception-Implants-and-Intrauterine-Devices
- Wu JP, Moniz MH, Ursu AN.
Long-acting Reversible Contraception - Highly Efficacious,
Safe, and Underutilized.
JAMA. Published online July 6, 2018
PMID: 29984374
https://jamanetwork.com/journals/jama/fullarticle/2687700